Compile Data Set for Download or QSAR
Report error Found 458 with Last Name = 'langkopf' and Initial = 'e'
LigandPNGBDBM247001(({4-[5-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  109nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

LigandPNGBDBM246998(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  282nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301723([(S)-6-{(R)-7-Fluoro-4-[4-(1H-tetrazol-5-yl)-pheno...)
Affinity DataEC50:  282nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301754(((S)-6-{(R)-4-[3-Cyano-4-(3-hydroxy-3-methylbutoxy...)
Affinity DataEC50:  7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301772(((S)-6-{(R)-4-[2-Cyano-4-(3-hydroxy-3-methylbutyl)...)
Affinity DataEC50:  12nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301725([(S)-6-{(R)-7-Fluoro-4-[4-(2-methyl-2H-tetrazol-5-...)
Affinity DataEC50:  3nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301727({(S)-6-[(R)-7-Fluoro-4-(4-imidazol-1-yl-phenoxy)-i...)
Affinity DataEC50:  23nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240772(US9422312, 8)
Affinity DataEC50:  61nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301714([(S)-6-{(R)-7-Fluoro-4-[4-(3-methanesulfonyl-propo...)
Affinity DataEC50:  15nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM247002(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  71nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301735({(S)-6-[(R)-4-(Benzo[d][1,3]dioxol-5-yloxy)-7-fluo...)
Affinity DataEC50:  6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301712([(S)-6-{(R)-7-Fluoro-4-[4-(3-hydroxy-3-methyl-buto...)
Affinity DataEC50:  5nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301724([(S)-6-{(R)-4-[3-(Acetylamino-methyl)-phenoxy]-7-f...)
Affinity DataEC50:  23nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301726({(S)-6-[(R)-7-fluoro-4-{2-[(S)-tetrahydro-furan-3-...)
Affinity DataEC50:  9nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301736({(S)-6-[(R)-4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl...)
Affinity DataEC50:  6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM246992(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  302nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

LigandPNGBDBM246999(({6-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  193nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301730({(S)-6-[(R)-4-{3,5-Difluoro-4-[1-(2-hydroxy-2-meth...)
Affinity DataEC50:  7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240774(US9422312, 10)
Affinity DataEC50:  17nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240770(US9422312, 6)
Affinity DataEC50:  54nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301756(((S)-6-{(R)-7-Fluoro-4-[2-fluoro-5-(tetrahydro-2H-...)
Affinity DataEC50:  62nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240768(US9422312, 4)
Affinity DataEC50:  52nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301720({(S)-6-[(R)-7-Fluoro-4-(4-imidazol-1-yl-phenoxy)-i...)
Affinity DataEC50:  11nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301757(((S)-6-{(R)-4-[2-Cyano-4-(3-hydroxy-3-methylbutoxy...)
Affinity DataEC50:  8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301760(((S)-6-{(R)-7-Fluoro-4-[2-fluoro-4-(tetrahydro-2H-...)
Affinity DataEC50:  4nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301773(((S)-6-{(R)-4-[4-(Dimethylcarbamoyl)phenoxy]-7-flu...)
Affinity DataEC50:  22nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301713([(S)-6-{(R)-7-Fluoro-4-[4-(2-hydroxy-2-methyl-prop...)
Affinity DataEC50:  13nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301731([(S)-6-{(R)-7-Fluoro-4-[4-(1H-tetrazol-5-yl)-pheno...)
Affinity DataEC50:  6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301758({(S)-6-[(R)-4-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl...)
Affinity DataEC50:  9nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240783(US9422312, 20)
Affinity DataEC50:  82nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301762(((S)-6-{(R)-4-[4-Cyano-3-(2-hydroxy-2-methylpropro...)
Affinity DataEC50:  31nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240766(US9422312, 2)
Affinity DataEC50:  20nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM240779(US9422312, 15)
Affinity DataEC50:  90nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM246890((3R,3aR,6R,6aR)-6-(6-Chloro-5-iodo-3-(2-trimethyls...)
Affinity DataEC50:  284nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301743(((S)-6-{(R)-7-Fluoro-4-[4-(3-hydroxy-3-methylbutyl...)
Affinity DataEC50:  45nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301716({(S)-6-[(R)-4-(3-Acetylamino-phenoxy)-7-fluoro-ind...)
Affinity DataEC50:  8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301761(2,5-Difluoro-4-[1-(2-hydroxy-2-methyl-propyl)-1H-p...)
Affinity DataEC50:  29nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301765(((S)-6-{(R)-7-Fluoro-4-[2-fluoro-4-(1-methyl-1H-py...)
Affinity DataEC50:  6nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301710([(S)-6-Hydroxy-2,3-dihydro-benzofuran-3-yl]-acetic...)
Affinity DataEC50:  7nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301715({(S)-6-[(R)-7-Fluoro-4-hydroxy-indan-1-yloxy]-2,3-...)
Affinity DataEC50:  25nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

LigandPNGBDBM240771(US9422312, 7)
Affinity DataEC50:  37nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

LigandPNGBDBM246995(({4-[4-(2-{[(3R,3aR,6R,6aR)-6-Hydroxy-hexahydrofur...)
Affinity DataEC50:  450nMpH: 7.0 T: 2°CAssay Description:The test compounds were dissolved in 100% DMSO at a concentration of 10 mM and in a first step diluted in DMSO to a concentration of 5 mM, followed b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2018
Entry Details
Go to US Patent

LigandPNGBDBM240777(US9422312, 13)
Affinity DataEC50:  30nMpH: 7.0 T: 2°CAssay Description:In the 384-well plates 1.25 μl of test compound in assay buffer was mixed with 1.25 μl of AMPK and 1.25 μl of the peptide (final concentrati...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/1/2017
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301775(((S)-6-{(R)-7-Fluoro-4-[4-(3-hydroxy-3-methylbutox...)
Affinity DataEC50:  44nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301759(((S)-6-{(R)-4-[4-(3,6-Dihydro-2H-pyran-4-yl)-pheno...)
Affinity DataEC50:  17nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301746(3,5-Difluoro-4-(1-(2-hydroxy-2-methylpropyl)-1H-py...)
Affinity DataEC50:  8nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301750({(S)-6-[(R)-4-(4-bromo-phenoxy)-7-fluoro-indan-1-y...)
Affinity DataEC50:  733nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301755(((S)-6-{(R)-7-Fluoro-4-[2-fluoro-5-(3-hydroxy-3-me...)
Affinity DataEC50:  29nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301729({(S)-6-[(R)-4-(4-Ethylcarbamoyl-phenoxy)-7-fluoro-...)
Affinity DataEC50:  12nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

TargetFree fatty acid receptor 1(Human)
Boehringer Ingelheim International

US Patent
LigandPNGBDBM301766([(S)-6-((R)-4-{2,6-Difluoro-4-[1-(2-hydroxy-2-meth...)
Affinity DataEC50:  38nMAssay Description:IP1 accumulation measurements using the IPOne assay system 1321N1 cells stably expressing human GPR40 receptor (Euroscreen, Belgium) are seeded 24 h ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 458 total ) | Next | Last >>
Jump to: